Cancer-Associated Venous Thromboembolic Disease, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.

Humans Venous Thromboembolism / etiology Neoplasms / complications Medical Oncology / standards Anticoagulants / therapeutic use Disease Management

Journal

Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515

Informations de publication

Date de publication:
Sep 2024
Historique:
medline: 6 9 2024
pubmed: 6 9 2024
entrez: 5 9 2024
Statut: ppublish

Résumé

The NCCN Guidelines for Cancer-Associated Venous Thromboembolic Disease provide strategies for the prevention, diagnosis, and treatment of venous thromboembolism (VTE) in adult patients with cancer. VTE is a common and life-threatening condition in patients with cancer, and its management often requires multidisciplinary efforts. The NCCN panel is comprised of specialists spanning various fields, including cardiology, hematology, medical oncology, internal medicine, interventional radiology, and pharmacology. The content featured in this issue specifically addresses the evaluation and recommended treatment options outlined in the NCCN Guidelines for the diverse subtypes of cancer-associated VTE.

Identifiants

DOI: 10.6004/jnccn.2024.0046 PMID: 39236759
pubmed: 39236759
doi: 10.6004/jnccn.2024.0046
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

483-506

Auteurs

Michael B Streiff (MB)

1The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Bjorn Holmstrom (B)

2Moffitt Cancer Center.

Dana Angelini (D)

3Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Aneel Ashrani (A)

4Mayo Clinic Comprehensive Cancer Center.

Tyler Buckner (T)

5University of Colorado Cancer Center.

Robert Diep (R)

6Stanford Cancer Institute.

Kleber Yotsumoto Fertrin (KY)

7Fred Hutchinson Cancer Center.

Annemarie E Fogerty (AE)

8Mass General Cancer Center.

Nicolas Gallastegui Crestani (NG)

9The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

Radhika Gangaraju (R)

10O'Neal Comprehensive Cancer Center at UAB.

Cristhiam Rojas-Hernandez (C)

11The University of Texas MD Anderson Cancer Center.

Samuel Z Goldhaber (SZ)

12Dana-Farber/Brigham and Women's Cancer Center.

Ibrahim Ibrahim (I)

13UT Southwestern Simmons Comprehensive Cancer Center.

Timothy Kubal (T)

2Moffitt Cancer Center.

Andrew D Leavitt (AD)

14UCSF Helen Diller Family Comprehensive Cancer Center.

Ming Lim (M)

15Huntsman Cancer Institute at the University of Utah.

Janelle Mann (J)

16Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

Simon Mantha (S)

17Memorial Sloan Kettering Cancer Center.

Colleen Morton (C)

18Vanderbilt-Ingram Cancer Center.

Alex Nester (A)

19Fred & Pamela Buffett Cancer Center.

Andrew O'Brien (A)

20Indiana University Melvin and Bren Simon Comprehensive Cancer Center.

Thomas L Ortel (TL)

21Duke Cancer Institute.

Alexander Pine (A)

22Yale Cancer Center/Smilow Cancer Hospital.

Allyson Pishko (A)

23Abramson Cancer Center at the University of Pennsylvania.

Mona Ranade (M)

24UCLA Jonsson Comprehensive Cancer Center.

Amirali Salmasi (A)

25UC San Diego Moores Cancer Center.

Jordan Schaefer (J)

26University of Michigan Rogel Cancer Center.

Eliot Williams (E)

27University of Wisconsin Carbone Cancer Center.

Geoffrey Wool (G)

28The UChicago Medicine Comprehensive Cancer Network.

Theodore Wun (T)

29UC Davis Comprehensive Cancer Center.

Sarah Montgomery (S)

30National Comprehensive Cancer Network.

Jamie Nguyen (J)

30National Comprehensive Cancer Network.

Deborah Freedman-Cass (D)

30National Comprehensive Cancer Network.

Bailee Sliker (B)

30National Comprehensive Cancer Network.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Cancer-Associated Venous Thromboembolic...
questionsmedicales.fr › Maladies cardiovasculaires › Maladies vasculaires › Embolie et thrombose › Thromboembolie › Thromboembolisme veineux › Cancer-Associated Venous Thromboembolic...
questionsmedicales.fr › Tumeurs › Cancer-Associated Venous Thromboembolic...
questionsmedicales.fr › Professions de santé › Médecine › Médecine interne › Oncologie médicale › Cancer-Associated Venous Thromboembolic...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Agents hématologiques › Anticoagulants › Cancer-Associated Venous Thromboembolic...
questionsmedicales.fr › Administration des services de santé › Gestion des soins aux patients › Prise en charge de la maladie › Cancer-Associated Venous Thromboembolic...